Thanks @CGuillerey for quoting our work!
@CEIjournal @MaterResearch @UQ_News @TRI_info @helsinkiuni @joemarc_chauvin @yamanashi_univ @genentech @arcusbio @merckgroup @bmsnews @AstellasUS @PotenzaTx 5/n Should we test TIGIT in #HaematologicalCancers too? Probably: TIGIT acts in #TCells & #NKc
A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function. https://t.co/4lOlQuFKmA
RT @jitcancer: #JITC Research: A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function https://t.co/nlpBv…
RT @jitcancer: #JITC Research: A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function https://t.co/nlpBv…
#JITC Research: A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function https://t.co/nlpBvMhjTI https://t.co/M9EGbqmzdu
RT @sitcancer: New #JITC Research: A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function https://t.co/e…
New #JITC Research: A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function https://t.co/eY0lt5pz1e https://t.co/pJ7zFayjkH
A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function. by Hoogi S, Eisenberg V, Mayer S, Shamul A, Barliya T, Cohen CJ https://t.co/rQfO5AkyFl